BSE filing, NSE: VRLLOG. Summary written from the filing by ALFA Finder's alert engine.
VRL Logistics Ltd: key numbers
- Share price
- ₹270.00
- Market cap
- ₹4,723 Cr
- Revenue (annual)
- ₹3,221 Cr
- Net profit (annual)
- ₹236.8 Cr
- P/E (TTM)
- 17.7×Sector 30.1×
- Promoter holding
- 60.24%+0.00% QoQ
- FII holding
- 3.69%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from VRL Logistics Ltd
All →VRL Logistics Capital Structure Change
VRL Logistics opens its tender offer buyback for 87.5 lakh shares at ₹320 each, totalling ₹280 Crore. The offer window runs October 27 to November 2, 2026.
- Value
- ₹280.0 Cr
VRL Logistics Board Meeting Date
VRL Logistics will hold a board meeting on November 2, 2026 to approve reviewed results for the quarter and half year ended September 30, 2026. This is a notice of a future meeting, so no results are reported yet.
VRL Logistics Capital Structure Change
VRL Logistics Ltd has issued a corrigendum to its buyback announcement, revising the record date to October 22, 2026. The buyback consideration remains ₹280 Crore.
- Value
- ₹280.0 Cr
VRL Logistics Management Change
Mr. Ashok Shettar has resigned as a Non-Executive Director of VRL Logistics Limited, effective October 7, 2026, citing professional commitments.
VRL Logistics Annual General Meeting
VRL Logistics shareholders approved a special resolution for buyback of equity shares via postal ballot. The resolution passed unanimously with 100% of votes cast in favour.
VRL Logistics Capital Structure Change
VRL Logistics shareholders approved a buyback of up to 87,50,000 equity shares at Rs. 320 per share. Aggregate consideration not to exceed Rs. 280 Crore returns capital.
- Value
- ₹280.0 Cr
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.